Robuta

https://pubmed.ncbi.nlm.nih.gov/35120267/
COVID-19 significantly impairs survival rates among hematological patients when compared to the general population. Our prospective multicentre project...
sars covsuccessfulearlyuseanti
https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2017.00441/full
The development of an Adeno-associated virus (AAV) vector that can bypass pre-existing immunity in humans is crucial for universal application of this vector...
frontiersoptimizedaavrhvectors
https://www.news-medical.net/news/20220705/Deep-RNA-sequencing-with-molecular-dynamic-simulations-can-detect-neutralizing-antibodies-elicited-by-COVID-19-patients.aspx
In a new study, researchers reported on the non-ACE2 blocking neutralizing antibodies elicited in response to severe coronavirus disease 2019 using deep...
rna sequencingdeepmoleculardynamicsimulations
https://pubmed.ncbi.nlm.nih.gov/19114861/
Unprotected oral sex evokes a salivary IgA1-mediated HIV-neutralizing response that persists over time during continuous exposure in uninfected male partners...
neutralizing antibodiesoralhivexposureelicits
https://pubmed.ncbi.nlm.nih.gov/34045486/
In a randomized clinical trial of 86 hospitalized COVID-19 patients comparing standard care to treatment with 300mL convalescent plasma containing high titers...
neutralizing antibodiesconvalescent plasmaeffectspotentpatients
https://www.iavi.org/press-release/two-hiv-vaccine-trials-show-proof-of-concept-for-pathway-to-broadly-neutralizing-antibodies/
May 15, 2025 - Learn more about North American and African clinical trials led by Scripps Research, IAVI and collaborators that show early immune activation using mRNA...
proof of concepthiv vaccinetwotrialsshow
https://singlecelltechnology.com/resources/upfront-blocking-assay-to-discover-neutralizing-anti-sars-cov-2-antibodies
Single Cell Technology case study: Upfront Blocking Assay to Discover Neutralizing Anti-SARS-CoV-2 Antibodies. Set up in-line to save downstream time
sars covupfrontblockingassaydiscover
https://pubmed.ncbi.nlm.nih.gov/38753808/
Germline-targeting (GT) protein immunogens to induce VRC01-class broadly neutralizing antibodies (bnAbs) to the CD4-binding site of the HIV envelope (Env) have...
mrnalnpprimeboostevolves